Pregravid preparation in patients with the thin endometrium in assisted reproductive technology programs
Objective. To evaluate the efficiency of pregravid preparation using a specialized complex and hormonal therapy in patients with diagnosed infertility and clinical presentations of the thin endometrium.Serebrennikova K.G., Kuznetsova E.P., Vanke E.S., Ivanova T.V., Miloslavsky Yu.V.
Subjects and methods. The investigation enrolled 145 patients aged 25–42 years with an established diagnosis of infertility and a history of superovulation using GnRH agonists and antagonists. Group 1 included 65 patients who had undergone a surgery on the ovaries and received no pregravid preparation; Group 2 consisted of 60 patients who had a surgery on the ovaries and pregravid preparation for assisted reproductive technology (ART) programs during 2-3 months as the complex Pregnoton in combination with hormone therapy. The comparison group comprised 20 patients with intact ovaries and tuboperitoneal factor infertility. The investigation was conducted within the preparation of patients for an assisted reproductive technology protocol.
Results. After implementing the ART protocol, pregnancy occurred in 15.5, 31.7, and 35% of cases in Groups 1, 2, and 3, respectively.
Conclusion. Comprehensive pregravid preparation, including the complex Pregnoton in combination with hormonal therapy, makes it possible not only to increase the rate of pregnancy, but also to lower a risk for pregnancy complications, and thus affecting perinatal and infant losses.
Keywords
Supplementary Materials
- Table 1. Operative treatment in different groups of our investigation, n (%)
- Table 2. Analysis of the ovarian reserve before the IVF, M±m
- Table 3. The thickness of the endometrium of ultrasound investigation in different periods of the menstrual cycle, M±m
References
1. Kuznetsova I.V. Hormonal contraception and pregravid preparation: can it be combined? Problemyi reproduktsii. 2013; 1: 21-5. (in Russian)
2. Preprogrammed training: clinical protocol. Auto-comp. Radzinsky V.E. And others. Moscow: Editorial Board of the journal StatusPraesens; 2016. (in Russian)
3. Serebrennikova K.G., Vanke E.S., Kuznetsova E.P., Ivanova T.V., Miloslavskiy Yu.V. The effect of pregravid preparation in patients with operated ovaries in programs of assisted reproductive technologies. Ginekologiya. 2015; 17(4): 52-6. (in Russian)
4. Kalinchenko S.Yu., Zhilenko M.I., Gusakova D.A., Dyimova A.V. Preparation for pregnancy of women with endometrial hypoplasia. Ginekologiya. 2014; 16(5): 62-6. (in Russian)
5. Anshina M.B., Isakova E.V., Kalinina E.Anat., Kalinina E.Andr., Korsak V.S., Krasnopolskaya K.V., Nazarenko T.A., Serebrennikova K.G., Smirnova A.A., Smolnikova V.Yu. The use of estrogens in ART programs. Scientific and practical recommendations. Moscow: Russian Association of Human Reproduction; 2015. 80p. (in Russian)
6. Nazarenko T.A., Korsak V.S. Estrogens in reproductive medicine. Moscow: MEDpress-inform; 2016. (in Russian)
7. Gromova O.A., Torshin I.Yu., Dzhidzhihiya L.K., Gogoleva I.V. The role of vitamin D in the prevention and treatment of female infertility. Ginekologiya. 2016; 18(3): 34-9. (in Russian)
8. Elassar A., Mann J.S., Engmann L., Nulsen J., Benadiva C. Luteal phase estradiol versus luteal phase estradiol and antagonist protocol for controlled ovarian stimulation before in vitro fertilization in poor responders. Fertil. Steril. 2011; 95(1): 324-6.
9. Holick M.F. Vitamin D deficiency. N. Engl. J. Med. 2007; 357(3): 266-81.
10. Lerchbaum E., Rabe T. Vitamin D and female fertility. Curr. Opin. Obstet. Gynecol. 2014; 26(3): 145-50.
11. Kutlusoy F., Guler I., Erdem M., Erdem A,. Bozkurt N., Biberoglu E.H., Biberoglu K.O. Luteal phase support with estrogen in addition to progesterone increases pregnancy rates in in vitro fertilization cycles with poor response to gonadotropins. Gynecol. Endocrinol. 2014; 30(5): 363-6.
12. Ozkan S., Jindal S., Greenseid K., Shu J., Zeitlian G., Hickmon C., Pal L. Replete vitamin D stores predict reproductive success following IVF. Fertil. Steril. 2010; 94(4): 1314-9.
13. Rudick B., Ingles S., Chung K., Stanczyk F., Paulson R., Bendikson K. Characterizing the influence of vitamin D levels on IVF outcomes. Hum. Reprod. 2012; 27(11): 3321-7.
14. Chang X., Wu J. Effects of luteal estradiol pre-treatment on the outcome of IVF in poor ovarian responders. Gynecol. Endocrinol. 2013; 29(3): 196-200.
15. Romero-Aguirregomezcorta J., Santa A.P., Garcia-Vazquez F.A., Coy P., Matas C. Nitric Oxide Synthase (NOS) inhibition during porcine in vitro maturation modifies oocyte protein S-nitrosylation and in vitro fertilization. PLoS One. 2014; 9(12): e115004.
16. Wu G., Bazer F.W., Satterfield M.C., Li X., Wang X., Johnson G.A. et al. Impacts of arginine nutrition on embryonic and fetal development in mammals. Amino Acids. 2013; 45(2): 241-56.
17. Zeng X., Mao X., Huang Z., Wang F., Wu G., Qiao S. Arginine enhances embryo implantation in rats through PI3K/PKB/mTOR/NO signaling pathway during early pregnancy. Reproduction. 2013; 145(1): 1-7.
18. Kira E.F., Artyimuk N.V., Savicheva A.M., Rogovskaya S.I., Guschin A.E., Rumyantseva T.A., Ivanova O.V. The use of lactic acid in combination with glycogen for the treatment of bacterial vaginosis. Ginekologiya. 2015; 17(2): 93-6. (in Russian)
19. Rudick B.J., Ingles S.A., Chung K., Stanczyk F.Z., Paulson R.J., Bendikson K.A. Influence of vitamin D levels on in vitro fertilization outcomes in donor-recipient cycles. Fertil. Steril. 2014; 101(2): 447-52.
20. Farzadi L., Khayatzadeh Bidgoli H., Ghojazadeh M., Bahrami Z., Fattahi A., Latifi Z. et al. Correlation between follicular fluid 25-OH vitamin D and assisted reproductive outcomes. Iran. J. Reprod. Med. 2015; 13(6): 361-6.
21. Polyzos N.P., Anckaert E., Guzman L., Schiettecatte J., Van Landuyt L., Camus M. et al. Vitamin D deficiency and pregnancy rates in women undergoing single embryo, blastocyst stage, transfer (SET) for IVF/ICSI. Hum. Reprod. 2014; 29(9): 2032-40.
22. Shestakova I.G., Dicke G.B. Estrogen deficiency conditions in young women: what can we do? Estrogens in outpatient treatment of women of reproductive age. News bulletin. Radzinsky V.E., ed. Moscow: Editorial office of the journal StatusPraesens; 2016: №16. (in Russian)
23. Baerwald A.R., Pierson R.A. Endometrial development in association with ovarian follicular waves during the menstrual cycle. Ultrasound Obstet. Gynecol. 2004; 24(4): 453-60.
Received 16.12.2016
Accepted 23.12.2016
About the Authors
Serebrennikova Klara Georgievna, MD, professor, I.M. Sechenov 1st Moscow State Medical University; Scientific adviser on obstetrics and gynecologyat the Central Clinical Hospital of the Russian Academy of Sciences. 117593, Russia, Moscow, Lithuanian Boulevard, 1A. E-mail: klaraserebrennikova@mail.ru
Kuznetsova Elena Petrovna, MD, associate professor, chief freelance specialist of the Ministry of Health of the Udmurt Republic for reproduction,
head of the ECO Center and reproductions of The first republican clinical hospital, Ministry of Health of the Udmurt Republic.
426000, Russia, Izhevsk, Votkinskoye Highway, 57. E-mail: doctorfamily@mail.ru
Ivanova Tatyana Vitalievna, embryologist of the department of the ART, Central Clinical Hospital of the Russian Academy of Sciences.
117593, Russia, Moscow, Lithuanian Boulevard, 1A. E-mail: embryodoc@mail.ru
Vanke Ekaterina Sergeevna, obstetrician-gynecologist of the gynecological department of the Central Clinical Hospital of the Russian Academy of Sciences.
117593, Russia, Moscow, Lithuanian Boulevard, 1A. E-mail: vanke_katy@mail.ru
Miloslavsky Yuri Viktorovich, obstetrician-gynecologist of the gynecological department of the Central Clinical Hospital of the Russian Academy of Sciences.
117593, Russia, Moscow, Lithuanian Boulevard, 1A. E-mail: md_miloslavsky@mail.ru
For citations: Serebrennikova K.G., Kuznetsova E.P., Vanke E.S., Ivanova T.V., Miloslavsky Yu.V. Pregravid preparation in patients with the thin endometrium in assisted reproductive technology programs. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2017; (3): 139-46. (in Russian)
http://dx.doi.org/10.18565/aig.2017.3.139-46